| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |